Revision history of "Efficacy and also Basic safety regarding Anlotinib with regard to Patients using Superior NSCLC That Moved on Following Regular Regimens as well as the Initial Analysis of your Efficacy Forecaster"
From EECH Central
Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.